Error in Figure
In the original publication [1], there was an error in Figure 4. It was a typographical error, and did not affect the study results. The corrected Figure 4 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Figure 4.
(Phase 2) Survival (days) was compared between groups with no cavity, tumor cell injection, no resection; no cavity, standard tumor injection, resection; MRLS-created cavity, tumor cell implantation, no resection, and MRLS-created cavity, tumor cell implantation, resection—Surgical murine GBM resection model (Sur-rGBM). * p < 0.05 and ** p < 0.01 indicate a significant difference (n = 7).
Reference
- Das, A.; Stephens, H.R.; Baraso, R.; Garrison, J.; Mark, J.; Bailes, J.E.; Bobustuc, G.C.; Cachia, D.; Lindhorst, S.M. Development of a Murine Intracranial Surgical Resection Glioblastoma Model to Facilitate Preclinical In Vivo Drug Screening. Onco 2026, 6, 24. [Google Scholar] [CrossRef] [Scilit]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.